Community Acquired Pneumonia – updated HNELHD Guideline

As in these guidelines, benzylpenicillin or ampicillin remains the mainstay for treatment of community-acquired pneumonia worldwide. In severe pneumonia, use of a suitable aminoglycoside (based on local susceptibilities) is a good approach to provide for empiric Gram negative cover. Avoid use of ceftriaxone or fluoroquinolones for community respiratory tract infection – a key antimicrobial stewardship strategy! An alternative CAP severity scoring system is the SMART-COP system from Australia.

AIMED - Let's talk about antibiotics

The updated Hunter New England guideline,  Adult Community Acquired Pneumonia: Initial Investigation and Empiric Antibiotic Therapy has now been released.

Community acquired pneumonia (CAP) is a common cause of hospital admission, carrying a significant risk of morbidity and mortality.  Approximately 1/3 of patients require admission to hospital.  Streptococcus pneumoniae remains the commonest pathogen ( see here for local epidemiology).

Studies show that the use of clinical pathways for CAP treatment can reduce mortality, length of stay and ultimately cost.  Explicit assessment of severity is important. Severe cases should receive broad spectrum empiric therapy (usually intravenous) as soon as possible.

View original post 212 more words

About mdjkf

Microbiologist and Infectious Diseases Physician
This entry was posted in Infectious diseases and tagged , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s